MARKET

ZEAL

Zealand Pharma A/S
ZEAL
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.8338
16.86
11.46
813,876,564.84
Gubra appoints Adam Lange as head of investor relations
PUBT · 4d ago
ZEALAND PHARMA - TRANSACTIONS RELATED TO SHARE BUY-BACK PROGRAM (WEEKS 19-20, 2026)
Reuters · 05/14 15:00
LIVE MARKETS-Mixed earnings pull index in both directions
Reuters · 05/07 08:21
BUZZ-Buyback sends Zealand Pharma up 18% after sales beat
Reuters · 05/07 07:12
UPDATE 2-Zealand unveils buyback, Roche payments; shares rise
Reuters · 05/07 05:23
Zealand Pharma Q1 operating loss widens to DKK 539 million; revenue rises to DKK 34 million
PUBT · 05/07 05:02
ZEALAND PHARMA Q1 OPERATING RESULT DKK -539 MILLION
Reuters · 05/07 05:00
Zealand Pharma launches DKK 1.3 billion share buyback program
PUBT · 05/07 04:55
More

Webull offers Zealand Pharma A/S stock information, including NASDAQ: ZEAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZEAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZEAL stock methods without spending real money on the virtual paper trading platform.